Better Therapeutics, Inc.
BTTX · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | -100% | -55.6% | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | -8,425% | -4,888.9% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | -75,737.5% | -31,672.2% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | -79,837.5% | -32,194.4% |
| EPS Diluted | -1.69 | -1.71 | -1.04 | -0.25 |
| % Growth | 1.2% | -64.4% | -316% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |